Articles On CogState (ASX:CGS)

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Cogstate falls 7pc as clinical trials pipeline declines LBT Innovations delivers its technology to Thermo Fisher   Cogstate down after pipeline contracts Neuroscience biotech, Cogstate (ASX:CGS), tumbled by as much as -10% this morning af...

Last weekend a menagerie of lions, magpies, panthers and broncos battled for the silverware across our two major football codes. (Sorry Queensland. Twice!) How do investors get closer to the action, other than invading the pitch? While Aust...

Harvey Norman booted out of S&P ASX 100 as lithium play Liontown Resources admitted 2023 market darling of ASX biotech sector Neuren Pharmaceuticals a new addition to S&P ASX 200 The scent of blooming flowers, a gentle warming sun...

It should delight shareholders everywhere that 2023 has seen many ASX companies continue to buy up their own shares. Most investors are familiar with the primary way that an ASX share can return capital to its investors: by paying out divi...

The last five years have been the best of times and the worst of times for the Magellan Financial Group Ltd (ASX: MFG) share price. The stock leapt to an all-time high of around $65.50 in early 2020 before plummeting to a recent low of $7....

Ironically, ASX-listed investment companies have been out of favour with ASX investors in recent years. The depressed sentiment in share markets over the past 18 months hasn’t helped, with many customers pulling their money out to “safer”...

Ord Minnett says Aeris Resources could almost double Cogstate to benefit greatly from Alzheimer’s clinical trials   Could Aeris Resources go from 48c to 90c? Broker Ord Minnett has a Buy recommendation on diversified miner Aeris Resources...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

The ASX is set to fall on Wednesday after some gloomy earnings forecast on Wall Street Debt ceiling negotiations commence, with a potential US default on the line UBS says last night’s Budget was “stimulatory”, adding pressure on the RBA ...

Are you looking for growth stocks to buy? If you are, then you may want to check out the two listed below that brokers rate as buys. Here’s what analysts are saying about these ASX growth stocks right now: Allkem Ltd (ASX: AKE) The first...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

Well, it’s been another month, and another ASX notice confirming fund outflows for Magellan Financial Group Ltd (ASX: MFG).  Yesterday, we got the news that Magellan’s funds under management (FUM) continued to fall over April. The embattl...

If you’re looking for some new ASX 300 stocks to buy, then you may want to check out the three listed below that Goldman Sachs has just named as buys. Here’s why the broker is bullish on them: Jumbo Interactive Ltd (ASX: JIN) This onl...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) recovered from its lows but just fell short of positive territory. The benchmark index was down 4.3 points to 7,193.1 points. Will the market be able to bounce back from this on Friday? H...

The S&P/ASX 200 Index (ASX: XJO) opened Thursday’s session with a tumble before regaining most of its losses, closing the day 0.06% lower at 7,193.1 points. Its slump followed similar falls across the major indices of Wall Street. T...

The St Barbara Ltd (ASX: SBM) share price is glittering on Thursday. The gold miner’s shares were up 10% to 70.25 cents before being paused from trade. They have since come back and ended the day 7% higher at 68.5 cents. Why is the St Ba...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a modest decline. At the time of writing, the benchmark index is down slightly to 7,191.2 points. Four ASX shares that are not letting that hold them back ar...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to get into positive territory but has fallen just short. At the time of writing, the benchmark index is down slightly to 7,195.7 points. Four ASX shares that are f...

The S&P/ASX 200 Materials Index (ASX: XMJ) is rising 1.29% today, but this ASX mining stock is charging far higher. The Caspin Resources Ltd (ASX: CPN) share price gained 61% to hit an intraday high of 47.5 cents. It’s currently sett...

Vulcan Energy Resources Ltd (ASX: VUL) shares are going nowhere today after the company requested a trading halt and announced a capital raising. The S&P/ASX 300 Index (ASX: XKO) lithium stock is frozen at yesterday’s closing price of...

The ASX 200 climbed higher by 0.5% on the last day February, but was down 3% for the month Earnings were mixed today. CogState jumped while Harvey Norman slumped after their earnings reports Aussie retail sales rose in January   Aussie sh...

The All Ordinaries Index (ASX: XAO) is in the green today, gaining 0.49% to trade at 7,455.9 points, helped along by these stocks. They’re each gaining more than 7% on the back of strong first-half earnings. Let’s take a look at whatâ...

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.3% to 7,308.4 points. Four ASX shares that h...

Alcidion increased sales significantly in the first half Cogstate sounds warning on outlook Probiotic had a super half   Most biotech firms on the ASX are clinical stage companies, meaning they are still trying to prove that their drugs a...

A number of results have hit the All Ords today. Some have gone down well with investors, other have had them hitting the sell button. Three results that are in the latter category are summarised below. Here’s why investors are selling t...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX recovers to finish a bit less awful than it was at lunchtime, down 0.2% Magnis Energy Technologies climbs 6% on news that Elon wants to Bogart all its battery metals Connexion Telematics’ General Motors contract extension prompts an 80...

The S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Tuesday. In afternoon trade, the benchmark index is down 0.25% to 7,333.1 points. Four ASX shares that are falling more than most today are listed below. Here’s why they a...

Thanks to vaccines and better treatments for COVID-19, much of the developed world seems to have moved on from the pandemic. Even China, which had suffered from brutal zero-virus policies for three years, is starting to relax its stance de...

The Downer EDI Ltd (ASX: DOW) share price is under pressure again on Friday. In morning trade, the engineering and construction company’s shares are down a further 7% to $3.54. This means the Downer share price is now down 26% over the l...

The Downer EDI Ltd (ASX: DOW) share price is plummeting today after the company downgraded its guidance and revealed a historical accounting error with a potential $40 million impact. The engineering and construction company has identified...

The Woodside Energy Group Ltd (ASX: WDS) share price has been a strong performer over the past 12 months. And in November, the S&P/ASX 200 Index (ASX: XJO) oil and gas stock gained another 3.6%. The first part of November saw the Wood...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

If there has been a winner from the global energy shortage, it would have to be oil shares. Energy elites of the S&P/ASX 200 Index (ASX: XJO) have enjoyed enormous profits as conflicts crimp the supply of the commodity. For shareholde...

The Woodside Energy Group Ltd (ASX: WDS) share price is in the red today. Woodside shares are down 2% and currently fetching $35.91 apiece. For perspective, the S&P/ASX 200 Index (ASX: XJO) is sliding 0.56% today. Let’s take a look a...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a strong day and charged notably higher. The benchmark index rose 0.95% to 7,354.4 points. Will the market be able to build on this on Friday and end the week on a high? Here are five...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on form again and on course to record a solid gain. At the time of writing, the benchmark index is up 0.75% to 7,337.6 points. Four ASX shares that have failed to follow the mark...

Fund manager Wilson Asset Management (WAM) has identified two top small-cap ASX shares in one of the portfolios it manages that could be investment ideas. WAM operates several listed investment companies (LICs). Some, like WAM Leaders...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Healthcare is one of those industries that enjoys relatively stable demand through tougher economic times. With consecutive interest rises forcing Australians to close their wallets, this might be a consideration for the coming period. But...

It was another lousy month for the S&P/ASX 200 Index (ASX: XJO) as the benchmark index shed 7.3% to finish at 6,474 points. But as concerns over rising interest rates and inflation linger, it was no surprise to see ASX tech shares at t...

The S&P/ASX All Ordinaries Index (ASX: XAO) had another treacherous month in September as concerns of rising inflation and interest rates continued to rattle the market. The ASX All Ords index shed 7.6% across the month to close out Se...

As nerves mount for players on both NRL Grand Final sides preparing to line up at Staiudm Australia on Sunday night, it’s worth remembering the myriad enterprises that enable sportspeople to leap higher and kick further – while also tending...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is having a day to remember. At the time of writing, the benchmark index is up 1.8% to 6,579.1 points. Four ASX shares that are climbing more than most today are listed below. Here’s...

The Cogstate Limited (ASX: CGS) share price has continued its ascent on Thursday. In morning trade, the neuroscience technology company’s shares are up a further 17% to $2.24. Though, it is worth noting that the Cogstate share price was up...

Nasdaq-listed Biogen says its experimental Alzheimer’s drug study was successful The news sends ASX-listed Cogstate to soar Orthocell could have the first FDA-approved injectable cell therapy in orthopaedics  Big news out of Nasdaq-listed...

ASX 200 down 0.5% Small caps  crash about 1.1% OXR up 50% on some quality HR     And that’s how you say Wednesday was merde in French. Let’s do some good news first. Aussie retail sales climbed for an eighth consecutive month in August,...

The S&P/ASX 200 Index (ASX: XJO) has resumed its downward trend on Wednesday. In afternoon trade, the benchmark index is down 0.8% to 6,442.4 points. Four ASX shares that are not letting that hold them back today are listed below. Here...